UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine

Thrombosis and haemostasis, 1993, Vol.69 (3), p.240-246

1993

Volltextzugriff (PDF)

Primary Structure of Two-Chain Botrocetin, a von Willebrand Factor Modulator Purified from the Venom of Bothrops jararaca

Proceedings of the National Academy of Sciences - PNAS, 1993-02, Vol.90 (3), p.928-932

1993

Volltextzugriff (PDF)

Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca

Biochemistry (Easton), 1991-02, Vol.30 (7), p.1957-1964

1991

Volltextzugriff (PDF)

Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities

Biochemistry (Easton), 1991-11, Vol.30 (47), p.11286-11291

1991

Volltextzugriff (PDF)

A monoclonal antibody (NMC‐VIII/10) to factor VIII light chain recognizing Glu1675–Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells

British journal of haematology, 1992-08, Vol.81 (4), p.533-538

1992

Volltextzugriff (PDF)

Blood Clotting Factor IX Kashihara: Amino Acid Substitution of Valine-182 by Phenylalanine

Journal of biochemistry (Tokyo), 1989-05, Vol.105 (5), p.756-759

1989

Volltextzugriff (PDF)

Purification and Characterization of Bothrombin, a Fibrinogen-Clotting Serine Protease from the Venom of Bothrops jararaca

Biochemistry (Easton), 1994-02, Vol.33 (7), p.1843-1849

1994

Volltextzugriff (PDF)

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

The New England journal of medicine, 1990-12, Vol.323 (26), p.1800-1805

1990

Volltextzugriff (PDF)

Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata

Thrombosis research, 1986-06, Vol.42 (5), p.595-604

1986

Volltextzugriff (PDF)

Whole Platelet-Captured Enzyme Linked Immunosorbent Assay (WPC-ELISA) for Glycoprotein (GP) IIb/IIIa: I. Establishment of the Assay and its Normal Value

Japanese Journal of Thrombosis and Hemostasis, 1993/04/01, Vol.4(2), pp.69-76

1993

Volltextzugriff (PDF)

Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia A Patients

Japanese Journal of Thrombosis and Hemostasis, 1993/06/01, Vol.4(3), pp.179-188

1993

Volltextzugriff (PDF)

The ABO-blood group genotype in Japanese determined by polymerase chain reaction (PCR) using genomic DNA

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1992, Vol.38 (4), p.542-547

1992

Volltextzugriff (PDF)

Distribution of ABO blood group genotype in Nara prefecture and its familial diagnosis

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1993, Vol.39 (3), p.640-645

1993

Volltextzugriff (PDF)

Prevalence of antibodies to hepatitis C virus(HCV) in patients with hemophilla and its related disorders

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1991, Vol.37 (1), p.1-6

1991

Volltextzugriff (PDF)

A dental surgery of 2| radicular cyst in a patient with Bernard-Soulier syndrome using platelet concentrates prepared by a cell separator spectra (COBE)

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1991, Vol.37 (3), p.424-430

1991

Volltextzugriff (PDF)

Factor VIII Binding Ability of von Willebrand Factor in Several Fractions of Normal Plasma and Plasma from Several Types of von Willebrand Disease

Japanese Journal of Thrombosis and Hemostasis, 1991/04/01, Vol.2(2), pp.152-158

1991

Volltextzugriff (PDF)

Report on a selective anti-A agglutinin deficiency in a Japanese girl with blood phenotype O

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1991, Vol.37 (1), p.60-64

1991

Volltextzugriff (PDF)

Evaluation of HIV-2 antibody infection in Japanese hemophiliacs using a synthetic peptide immunoassay and polymerase chain reation

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1990, Vol.36 (5), p.574-579

1990

Volltextzugriff (PDF)

Properties of Factor VIII in the recombinant Factor VIII Concentrates (BAY w 6240)

Japanese Journal of Thrombosis and Hemostasis, 1990/06/01, Vol.1(3), pp.212-218

1990

Volltextzugriff (PDF)

Alboaggregin-B and Botrocetin, Two Snake Venom Proteins with Highly Homologous Amino Acid Sequences but Totally Distinct Functions on von Willebrand Factor Binding to Platelets

Biochemical and biophysical research communications, 1993-03, Vol.191 (3), p.1386-1392

1993

Volltextzugriff (PDF)

A long-term, multi-center clinical study of recombinant human factor VIII BAY w 6240) in treatment of hemophilia A

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1991, Vol.37 (5), p.593-604

1991

Volltextzugriff (PDF)

A Multicenter Clinical Study of Monoclonal Antibody-Purified Coagulation Factor IX Concentrate (GA-1013) in Treatment of Hemophilia B

Japanese Journal of Thrombosis and Hemostasis, 1991/08/01, Vol.2(4), pp.302-310

1991

Volltextzugriff (PDF)

Surgery of contracture on left knee joint in a patient with congenital factor X deficiency using Konyne

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1986, Vol.32 (1), p.18-22

1986

Volltextzugriff (PDF)

A monoclonal antibody (NMC‐VIII/10) to factor VIII light chain recognizing Glu 1675 –Glu 1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells

British journal of haematology, 1992-08, Vol.81 (4), p.533-538

1992

Volltextzugriff (PDF)

Factor VIII/von willebrand factor (FVIII/vWF) in a new intermediate factor VIII concentrate, RCG-5 Japan Red Cross

Nihon Yuketsu Gakkai zasshi = Journal of the Japan Society of Blood Transfusion, 1985, Vol.31 (4), p.296-300

1985

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(101)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(40)
Life Sciences & Biomedicine
(35)
Male
(21)
Female
(20)
Biological And Medical Sciences
(18)
Animals
(12)
Adult
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Amino Acid Sequence
(9)
Medical Sciences
(9)
Biochemistry & Molecular Biology
(8)
Molecular Sequence Data
(8)
Monoclonal Antibody
(8)
Factor Viii - Immunology
(7)
Molecular And Cellular Biology
(7)
Blood Coagulation. Blood Cells
(6)
Coagulation Factors
(6)
Elisa
(6)
Factor Ix
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine

Primary Structure of Two-Chain Botrocetin, a von Willebrand Factor Modulator Purified from the Venom of Bothrops jararaca

Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca

Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities

A monoclonal antibody (NMC‐VIII/10) to factor VIII light chain recognizing Glu1675–Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells

Blood Clotting Factor IX Kashihara: Amino Acid Substitution of Valine-182 by Phenylalanine

Purification and Characterization of Bothrombin, a Fibrinogen-Clotting Serine Protease from the Venom of Bothrops jararaca

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

Heterogeneity of factor IX BM difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata

Whole Platelet-Captured Enzyme Linked Immunosorbent Assay (WPC-ELISA) for Glycoprotein (GP) IIb/IIIa: I. Establishment of the Assay and its Normal Value

Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia A Patients

The ABO-blood group genotype in Japanese determined by polymerase chain reaction (PCR) using genomic DNA

Distribution of ABO blood group genotype in Nara prefecture and its familial diagnosis

Prevalence of antibodies to hepatitis C virus(HCV) in patients with hemophilla and its related disorders

A dental surgery of 2| radicular cyst in a patient with Bernard-Soulier syndrome using platelet concentrates prepared by a cell separator spectra (COBE)

Factor VIII Binding Ability of von Willebrand Factor in Several Fractions of Normal Plasma and Plasma from Several Types of von Willebrand Disease

Report on a selective anti-A agglutinin deficiency in a Japanese girl with blood phenotype O

Evaluation of HIV-2 antibody infection in Japanese hemophiliacs using a synthetic peptide immunoassay and polymerase chain reation

Properties of Factor VIII in the recombinant Factor VIII Concentrates (BAY w 6240)

Alboaggregin-B and Botrocetin, Two Snake Venom Proteins with Highly Homologous Amino Acid Sequences but Totally Distinct Functions on von Willebrand Factor Binding to Platelets

A long-term, multi-center clinical study of recombinant human factor VIII BAY w 6240) in treatment of hemophilia A

A Multicenter Clinical Study of Monoclonal Antibody-Purified Coagulation Factor IX Concentrate (GA-1013) in Treatment of Hemophilia B

Surgery of contracture on left knee joint in a patient with congenital factor X deficiency using Konyne

A monoclonal antibody (NMC‐VIII/10) to factor VIII light chain recognizing Glu 1675 –Glu 1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells

Factor VIII/von willebrand factor (FVIII/vWF) in a new intermediate factor VIII concentrate, RCG-5 Japan Red Cross

Suchergebnisse filtern